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Objective: Schaaf-Yang syndrome (SYS) is a neurodevelopmental disorder caused by truncating 
variants in the paternal allele of MAGEL2, located in the Prader-Willi critical region, 15q11-q13. 
Although the phenotypes of SYS overlap those of Prader-Willi syndrome (PWS), including neonatal 
hypotonia, feeding problems, and developmental delay/intellectual disability, SYS patients show 
autism spectrum disorder and joint contractures, which are atypical phenotypes for PWS. Therefore, 
we hypothesized that the truncated Magel2 protein could potentially produce gain-of-function toxic 
effects. To test the hypothesis, we generated two engineered mouse models; one, an overexpression 
model that expressed the N-terminal region of Magel2 that was FLAG tagged with a strong ubiquitous 
promoter, and another, a genome-edited model that carried a truncating variant in Magel2 generated 
using the CRISPR/Cas9 system.  
Results: In the overexpression model, all transgenic mice died in the fetal or neonatal period indicating 
embryonic or neonatal lethality of the transgene. Therefore, overexpression of the truncated Magel2 
could show toxic effects. In the genome-edited model, we generated a mouse model carrying a 
frameshift variant (c.1690_1924del; p(Glu564Serfs*130)) in Magel2. Model mice carrying the 
frameshift variant in the paternal or maternal allele of Magel2 were termed Magel2P:fs and Magel2M:fs, 
respectively. The imprinted expression and spatial distribution of truncating Magel2 transcripts in the 
brain were maintained. Although neonatal Magel2P:fs mice were lighter than wildtype littermates, 
Magel2P:fs males and females weighed the same as their wildtype littermates by eight and four weeks 
of age, respectively.  
Discussion: Collectively, the overexpression mouse model may recapitulate fetal or neonatal death, 
which are the severest phenotypes for SYS. In contrast, the genome-edited mouse model maintains 
genomic imprinting and distribution of truncated Magel2 transcripts in the brain, but only partially 
recapitulates SYS phenotypes. Therefore, our results imply that simple gain-of-function toxic effects 
may not explain the patho-mechanism of SYS, but rather suggest a range of effects due to Magel2 
variants as in human SYS patients. 
